Patient Advocacy Groups Mixed On Sanders’ Long COVID Proposal

Long COVID patient-advocacy groups offered mixed reviews in their feedback to Senate health committee Chair Bernie Sanders’ (I-VT) $10 billion research proposal ahead of his Tuesday (April 23) deadline for input. They broadly agree the final bill should place more emphasis on long COVID's potential pathology of viral persistence and should actively involve Black Americans and other underserved communities in the research and advisory processes, but they disagree on funding levels and broader research goals. The feedback resurfaced longstanding fault...